Retatrutide 12mg
$155.99
Retatrutide is a novel multi-receptor peptide agonist studied for its action on GLP-1, GIP, and glucagon receptors. In preclinical models, it may support research into appetite regulation, weight loss, and glucose metabolism.
⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.
Description
Retatrutide is an investigational synthetic peptide designed as a triple agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This next-generation incretin mimetic is being researched for its superior metabolic effects compared to single or dual agonists. Preclinical data suggests it may significantly reduce body weight, regulate blood glucose, and promote lipid metabolism through multi-pathway signaling.
Retatrutide’s unique activity profile positions it as a promising tool in research on obesity, type 2 diabetes, and metabolic syndrome, with enhanced energy expenditure and appetite suppression observed in animal models.
How Retatrutide Works (Based on Preclinical Research):
-
Activates GLP-1 receptors to improve insulin sensitivity and slow gastric emptying
-
Stimulates GIP receptors to enhance insulin secretion and fat metabolism
-
Engages glucagon receptors to promote energy expenditure and lipolysis
-
Synergistic receptor activation supports comprehensive metabolic modulation
Potential Benefits (Based on Preclinical Research):
-
Significant reduction in body weight and fat mass
-
Improved glycemic control and insulin sensitivity
-
Appetite suppression and increased satiety
-
Enhanced lipid oxidation and energy utilization
⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.
Reviews
There are no reviews yet.